View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2030-05-20 |
| Par Value | 1000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 750.00 |
| Coupon | 2.823 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 750 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Becton Dickinson & Co. corporate note has a 2.82% fixed rate coupon paid on a semi-annual basis. It was issued on May 20, 2020 with an issue size of 750.00 million USD and matures on May 20, 2030 with a last coupon date of November 20, 2029. |
Becton Dickinson & Co., founded in 1897 and headquartered in Franklin Lakes, New Jersey, is a global leader in medical technology aimed at advancing healthcare outcomes. The company develops and manufactures a wide range of medical devices, instrument systems, and reagents, prominently known for its innovations in diabetes care, medication management, and infection prevention.